PTC Therapeutics (NASDAQ:PTCT)

CAPS Rating: 1 out of 5

Results 1 - 22 of 25
Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
capstrarian 66.59 11/21/2014 Outperform 5Y $40.17 -1.00% -0.46% -0.53 0 Comment
wilsafris < 20 8/25/2014 Outperform 5Y $31.71 +25.42% +3.28% +22.14 0 Comment
mavericktrading 99.73 8/15/2014 Underperform 5Y $32.88 +20.95% +6.13% -14.83 0 Comment
roog < 20 7/24/2014 Outperform 5Y $28.61 +39.01% +3.95% +35.06 0 Comment
noataluren < 20 5/28/2014 Underperform 1Y $23.38 +70.10% +7.91% -62.20 1 Comment
HoldThatWinner 30.70 5/27/2014 Underperform 1Y $20.23 +96.59% +8.18% -88.41 0 Comment
cashole 99.61 5/27/2014 Underperform 3M $20.23 +96.59% +8.18% -88.41 0 Comment
pro64grammer 29.03 5/23/2014 Underperform 5Y $23.40 +69.96% +8.63% -61.33 0 Comment
joe508mama 33.93 5/23/2014 Underperform 5Y $22.54 +76.43% +8.69% -67.75 0 Comment
ClientNein 99.87 5/23/2014 Underperform 5Y $22.90 +73.64% +8.64% -65.00 0 Comment
stockshakers93 48.53 5/23/2014 Outperform NS $27.69 +43.63% +8.92% +34.70 0 Comment
NuevaVida 98.58 5/8/2014 Underperform 5Y $17.80 +123.43% +9.49% -113.93 0 Comment
acekeldog 98.89 4/29/2014 Underperform 1Y $19.24 +106.70% +10.02% -96.68 0 Comment
portefeuille3 98.58 4/11/2014 Outperform 5Y $19.55 +103.43% +13.84% +89.59 0 Comment
portefeuille2 99.66 4/11/2014 Outperform 5Y $19.76 +101.27% +13.66% +87.60 0 Comment
portefeuille 99.61 4/10/2014 Outperform 5Y $20.15 +97.37% +12.69% +84.68 0 Comment
SimonSaysSell 97.96 1/27/2014 Underperform NS $26.63 +49.34% +15.42% -33.92 0 Comment
thebeef41 49.47 10/2/2013 Underperform 1Y $20.71 +92.03% +22.48% -69.55 0 Comment
ababrmon 94.67 7/15/2013 Underperform 1Y $17.30 +129.88% +23.17% -106.71 0 Comment
flypower 98.25 7/3/2013 Outperform 5Y $16.24 +144.89% +28.56% +116.33 0 Comment
hungarian1 29.48 7/1/2013 Underperform 5Y $14.87 +167.45% +27.41% -140.04 0 Comment
AlexeiVronsky 97.07 6/24/2013 Outperform 5Y $17.25 +130.55% +31.30% +99.25 0 Comment
Results 1 - 22 of 25

Featured Broker Partners


Advertisement